{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:24:42Z","timestamp":1740165882102,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-022-00728-9","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T03:24:46Z","timestamp":1660965886000},"page":"104-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bystander LECT2 amyloidosis in tumor nephrectomy"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3180-6133","authenticated-orcid":false,"given":"A. J.","family":"Gallan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bhasin-Chhabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kilari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"issue":"6","key":"728_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583\u201396. https:\/\/doi.org\/10.1056\/NEJMra023144.","journal-title":"N Engl J Med"},{"issue":"4","key":"728_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","volume":"27","author":"MD Benson","year":"2020","unstructured":"Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, et al. Amyloid nomenclature 2020: update and recommendations by the international society of amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27(4):217\u201322. https:\/\/doi.org\/10.1080\/13506129.2020.1835263.","journal-title":"Amyloid"},{"issue":"2","key":"728_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ki.2008.152","volume":"74","author":"MD Benson","year":"2008","unstructured":"Benson MD, James S, Scott K, Liepnieks JJ, Kluve-Beckerman B. Leukocyte chemotactic factor 2: a novel renal amyloid protein. Kidney Int. 2008;74(2):218\u201322. https:\/\/doi.org\/10.1038\/ki.2008.152.","journal-title":"Kidney Int"},{"issue":"11","key":"728_CR4","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.2215\/cjn.12551214","volume":"10","author":"SH Nasr","year":"2015","unstructured":"Nasr SH, Dogan A, Larsen CP. Leukocyte cell-derived chemotaxin 2-associated amyloidosis: a recently recognized disease with distinct clinicopathologic characteristics. Clin J Am Soc Nephrol. 2015;10(11):2084\u201393. https:\/\/doi.org\/10.2215\/cjn.12551214.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"728_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ki.2010.9","volume":"77","author":"CP Larsen","year":"2010","unstructured":"Larsen CP, Walker PD, Weiss DT, Solomon A. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int. 2010;77(9):816\u20139. https:\/\/doi.org\/10.1038\/ki.2010.9.","journal-title":"Kidney Int"},{"issue":"3","key":"728_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","volume":"90","author":"FB Cortazar","year":"2016","unstructured":"Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, et al. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int. 2016;90(3):638\u201347. https:\/\/doi.org\/10.1016\/j.kint.2016.04.008.","journal-title":"Kidney Int"},{"issue":"6","key":"728_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1053\/j.ajkd.2019.04.016","volume":"74","author":"AJ Gallan","year":"2019","unstructured":"Gallan AJ, Alexander E, Reid P, Kutuby F, Chang A, Henriksen KJ. Renal vasculitis and pauci-immune glomerulonephritis associated with immune checkpoint inhibitors. Am J Kidney Dis. 2019;74(6):853\u20136. https:\/\/doi.org\/10.1053\/j.ajkd.2019.04.016.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"728_CR8","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/PAS.0b013e31804ca63e","volume":"31","author":"KJ Henriksen","year":"2007","unstructured":"Henriksen KJ, Meehan SM, Chang A. Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases. Am J Surg Pathol. 2007;31(11):1703\u20138. https:\/\/doi.org\/10.1097\/PAS.0b013e31804ca63e.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"728_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1043\/1543-2165-133.7.1012","volume":"133","author":"KJ Henriksen","year":"2009","unstructured":"Henriksen KJ, Meehan SM, Chang A. Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. Arch Pathol Lab Med. 2009;133(7):1012\u201325. https:\/\/doi.org\/10.1043\/1543-2165-133.7.1012.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"728_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.pas.0000194296.74097.87","volume":"30","author":"V Bijol","year":"2006","unstructured":"Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nos\u00e9 V. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol. 2006;30(5):575\u201384. https:\/\/doi.org\/10.1097\/01.pas.0000194296.74097.87.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"728_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/ajcp\/aqab048","volume":"156","author":"C Dernell","year":"2021","unstructured":"Dernell C, Bhasin B, Iczkowski KA, Gallan AJ. Characterization of the peritumoral atrophic band and nonneoplastic renal parenchyma in radical nephrectomy specimens. Am J Clin Pathol. 2021;156(5):913\u20139. https:\/\/doi.org\/10.1093\/ajcp\/aqab048.","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"728_CR12","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.4065\/75.12.1236","volume":"75","author":"WK Lau","year":"2000","unstructured":"Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75(12):1236\u201342. https:\/\/doi.org\/10.4065\/75.12.1236.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"728_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/PAP.0b013e3182a92dc3","volume":"20","author":"MM Picken","year":"2013","unstructured":"Picken MM. Modern approaches to the treatment of amyloidosis: the critical importance of early detection in surgical pathology. Adv Anat Pathol. 2013;20(6):424\u201339. https:\/\/doi.org\/10.1097\/PAP.0b013e3182a92dc3.","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"728_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ki.2014.11","volume":"86","author":"CP Larsen","year":"2014","unstructured":"Larsen CP, Kossmann RJ, Beggs ML, Solomon A, Walker PD. Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis. Kidney Int. 2014;86(2):378\u201382. https:\/\/doi.org\/10.1038\/ki.2014.11.","journal-title":"Kidney Int"},{"issue":"2","key":"728_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.2012.108","volume":"82","author":"S Sethi","year":"2012","unstructured":"Sethi S, Vrana JA, Theis JD, Leung N, Sethi A, Nasr SH, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int. 2012;82(2):226\u201334. https:\/\/doi.org\/10.1038\/ki.2012.108.","journal-title":"Kidney Int"},{"key":"728_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-pathol-052016-100200","volume":"12","author":"DA Amyloidosis","year":"2017","unstructured":"Amyloidosis DA. Insights from Proteomics. Annu Rev Pathol. 2017;12:277\u2013304. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100200.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"728_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/13506129.2016.1145110","volume":"23","author":"CP Larsen","year":"2016","unstructured":"Larsen CP, Beggs ML, Wilson JD, Lathrop SL. Prevalence and organ distribution of leukocyte chemotactic factor 2 amyloidosis (ALECT2) among decedents in New Mexico. Amyloid. 2016;23(2):119\u201323. https:\/\/doi.org\/10.3109\/13506129.2016.1145110.","journal-title":"Amyloid"},{"issue":"4","key":"728_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/modpathol.2016.29","volume":"29","author":"CP Larsen","year":"2016","unstructured":"Larsen CP, Ismail W, Kurtin PJ, Vrana JA, Dasari S, Nasr SH. Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians. Mod Pathol. 2016;29(4):416\u201320. https:\/\/doi.org\/10.1038\/modpathol.2016.29.","journal-title":"Mod Pathol"},{"issue":"5","key":"728_CR19","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1053\/j.ajkd.2014.06.017","volume":"64","author":"HL Hutton","year":"2014","unstructured":"Hutton HL, DeMarco ML, Magil AB, Taylor P. Renal leukocyte chemotactic factor 2 (LECT2) amyloidosis in first nations people in northern british columbia, canada: a report of 4 cases. Am J Kidney Dis. 2014;64(5):790\u20132. https:\/\/doi.org\/10.1053\/j.ajkd.2014.06.017.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"728_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/ijn.IJN_258_19","volume":"30","author":"K Singh","year":"2020","unstructured":"Singh K, Sethi J, Duggal R, Joshi K, Bains AS. Rare, yet emerging cause of graft dysfunction-ALECT 2 amyloidosis. Indian J Nephrol. 2020;30(3):204\u20136. https:\/\/doi.org\/10.4103\/ijn.IJN_258_19.","journal-title":"Indian J Nephrol"},{"issue":"1","key":"728_CR21","doi-asserted-by":"publisher","first-page":"e2015043","DOI":"10.4084\/mjhid.2015.043","volume":"7","author":"U Kulkarni","year":"2015","unstructured":"Kulkarni U, Valson A, Korula A, Mathews V. Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis. Mediterr J Hematol Infect Dis. 2015;7(1):e2015043. https:\/\/doi.org\/10.4084\/mjhid.2015.043.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"728_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/ndt\/gfw375","volume":"33","author":"T Rezk","year":"2018","unstructured":"Rezk T, Gilbertson JA, Rowczenio D, Bass P, Lachmann HJ, Wechalekar AD, et al. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis. Nephrol Dial Transplant. 2018;33(2):241\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfw375.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"728_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/ki.2013.558","volume":"86","author":"SM Said","year":"2014","unstructured":"Said SM, Sethi S, Valeri AM, Chang A, Nast CC, Krahl L, et al. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int. 2014;86(2):370\u20137. https:\/\/doi.org\/10.1038\/ki.2013.558.","journal-title":"Kidney Int"},{"key":"728_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ctrv.2017.06.002","volume":"58","author":"M Sznol","year":"2017","unstructured":"Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, et al. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017;58:70\u20136. https:\/\/doi.org\/10.1016\/j.ctrv.2017.06.002.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"728_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/pas.0000000000000373","volume":"39","author":"VS Chandan","year":"2015","unstructured":"Chandan VS, Shah SS, Lam-Himlin DM, Petris GD, Mereuta OM, Dogan A, et al. Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis. Am J Surg Pathol. 2015;39(4):558\u201364. https:\/\/doi.org\/10.1097\/pas.0000000000000373.","journal-title":"Am J Surg Pathol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00728-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00728-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00728-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T14:40:17Z","timestamp":1675262417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00728-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00728-9","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}